STD DEV GROUP (01867): Zhao Changsheng and Xu Zhaohong Appointed as Independent Non-Executive Directors

Stock News
2025/09/30

STD DEV GROUP (01867) announced that Mr. Liang Rongjin and Dr. Yan Bing have informed the Board that they will not seek re-election and will retire from their director positions at the conclusion of the Annual General Meeting. Their decision follows consideration of their continuous tenure, the Stock Exchange's independence requirements, and their intention to dedicate more time to personal affairs.

At the Annual General Meeting, shareholders approved the appointment of Mr. Zhao Changsheng and Mr. Xu Zhaohong as independent non-executive directors.

Following the retirement of Mr. Liang and Dr. Yan at the Annual General Meeting, Mr. Liang ceased to serve as Chairman of the Board Remuneration Committee and as a member of both the Board Nomination Committee and Board Audit Committee. Dr. Yan ceased to serve as a member of the Audit Committee.

Effective from the conclusion of the Annual General Meeting, Mr. Zhao has been appointed as Chairman of the Remuneration Committee and as a member of both the Audit Committee and Nomination Committee. Mr. Xu has been appointed as a member of the Audit Committee.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10